Financial and Development Team

The Financial and Development Team at Step Pharma is responsible for overseeing the strategic allocation of financial resources and ensuring the successful development of novel nucleotide synthesis inhibitors. This team collaborates closely with research and clinical departments to manage budgets, assess financial viability, and drive the progression of therapies targeting CTPS1, while also providing leadership in financial planning and operational execution to support the company’s long-term goals.